News

Article

Hawaiian Eye: Focus on the retina program 2024 in the tropics

Author(s):

The Retina Program 2024 will convene during the Hawaiian Eye meeting in Maui from January 14 through January 19

(Image Credit: AdobeStock/elena_suvorova)

(Image Credit: AdobeStock/elena_suvorova)

The Retina Program 2024 will convene during the Hawaiian Eye meeting in Maui from January 14 through January 19. The venue is the Grand Wailea Maui at the southern end of the island.

According to the organizers, the program, which is designed by and for retina specialists, will focus on updates on the most recent advances in the subspecialty, their integration into everyday practice, and insights into varying challenges, including the implementation of new diagnostic and treatment modalities.

The attendees will have the opportunity to discuss specific cases, new therapies, imaging technologies, and the latest surgical strategies. This program offers breakfast programs, general sessions, exhibit breaks, lunch programs, workshops, banyan tree sessions, and special events such as a luau on January 18, which requires separate registration through the resort.

Participants in the Retina Program also will have access to sessions of interest under the Hawaiian Eye Comprehensive Ophthalmologist Program.

Those interested in the Retina Program can register online.

Meeting highlights

The following is a sampling of what is available during the program.

Sunday, January 14

Features a CME breakfast seminar: Geographic Atrophy: Recent Developments in a Rapidly Evolving Therapeutic Landscape; Changing Ophthalmic Practice; the Lindstrom Leadership Award and Lecture; a CME lunch seminar: Retina360: Advances in the Management of Retinal Disease; and an industry workshop: Volux AND Skinvive: the Latest Innovations from Allergan Aesthetics for Jawline and Skin Quality.

Monday, January 15

Offers an industry expert theater breakfast: Treating Patients with Retinal Disease: Real-World Vabysmo Cases; Update on Imaging and New Technologies; Imaging and AMD Case Management; a CME lunch seminar: nAMD and DME Management: Scaling Real-World Heights in Durability – Featuring Curbside Consults!; HEALIO/OSN Disruptive Innovations; and a CME Banyan Tree Session.

Tuesday, January 16

Sessions include a CME breakfast seminar: From Theory to Practice: Personalized Approaches for Treating nAMD AND DME; Macular Degeneration; Abstract Presentations; Macular Degeneration: Panel Discussion; a CME lunch seminar: A Glimpse of Hope: Therapeutic Breakthroughs in the Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration; Dogs on the Beach!; and a CME Banyan Tree Session.

Wednesday, January 17

Offers a CME breakfast seminar: Achieving Optimal Outcomes with Uveitic Macular Edema Therapy: It’s All in the Delivery!; Diabetic Retinopathy and Retinal Vascular Disease; Abstract Presentations; Diabetic Retinopathy and Retinal Vascular Disease: Part 2; Diabetic Retinopathy and Retinal Vascular Disease: Panel Discussion; an industry expert theater lunch: An Expert Discussion of GALE 1-Year Data and Treating Appropriate Patients; and a CME Banyan Tree Session.

Thursday, January 18

Features Pediatric Retina, Uveitis, Endophthalmitis and Tumors; Abstract Presentations; Inherited Retinal Disease and Gene Therapy Update; a CME lunch seminar: Improving DME Treatment Using Biomarkers and Early Combination Therapy; a CME Banyan Tree Session; and a Hawaiian Luau.

Friday, January 19

Includes an industry expert theater breakfast: Integrating Anti-Inflammatory Treatment for Diabetic Macular Edema; a CME Breakfast Seminar; Surgery Update; Abstract Presentations; Best Cases Of 2023: Case Presentations and Panel Discussion; and a CME Lunch Seminar: Demodex Blepharitis: Eradicating a Mite-y Menace.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.